Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 7.40
0.00 (0.00%)
Oct 8, 2026, 2:57 PM CST
Pharmigene Market Cap
Pharmigene has a market cap or net worth of 373.44 million as of October 9, 2026. It is the 40,743rd most valuable company in the world and the 2,308th biggest in Taiwan. Its market cap has decreased by 39.84% in one year.
Market Cap
373.44M
Enterprise Value
922.30M
Revenue
187.88M
Global Rank
Country Rank
#2,308 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 373.44M, a decrease of -65.49%. That is a compound annual growth rate of -16.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 373.44M | -25.25% |
| Dec 31, 2025 | 499.60M | -30.53% |
| Dec 31, 2024 | 719.13M | -31.16% |
| Dec 29, 2023 | 1.04B | 21.08% |
| Dec 30, 2022 | 862.78M | -8.53% |
| Dec 30, 2021 | 943.19M | -13.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| DIVA Laboratories | 1.81B |
| Genetics Generation Advancement | 1.09B |
| Puriblood Medical | 1.06B |
| Kim Forest Enterprise | 815.18M |
| Sofiva Genomics | 720.14M |
| TFBS Bioscience | 662.10M |
| Welgene Biotech | 400.83M |